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Abstract 
Background: The current state of the science regarding the care and prognosis of patients with disorders of con‑
sciousness is limited. Scientific advances are needed to improve the accuracy, relevance, and approach to prognosti‑
cation, thereby providing the foundation to develop meaningful and effective interventions.
Methods: To address this need, an interdisciplinary expert panel was created as part of the Coma Science Working 
Group of the Neurocritical Care Society Curing Coma Campaign.
Results: The panel performed a gap analysis which identified seven research needs for prognostic modeling and 
trajectory analysis (“recovery science”) in patients with disorders of consciousness: (1) to define the variables that 
predict outcomes; (2) to define meaningful intermediate outcomes at specific time points for different endotypes; 
(3) to describe recovery trajectories in the absence of limitations to care; (4) to harness big data and develop analytic 
methods to prognosticate more accurately; (5) to identify key elements and processes for communicating prognostic 
uncertainty over time; (6) to identify health care delivery models that facilitate recovery and recovery science; and 
(7) to advocate for changes in the health care delivery system needed to advance recovery science and implement 
already‑known best practices.
Conclusion: This report summarizes the current research available to inform the proposed research needs, articulates 
key elements within each area, and discusses the goals and advances in recovery science and care anticipated by suc‑
cessfully addressing these needs.
Keywords: Brain injuries, Prognosis, Statistical models, Algorithms, Research, Outcome, Function, Recovery, 
Trajectories, Recovery science, Disorders of consciousness, Coma
Introduction
Considerable resources and scientific study are invested 
in the emergent and intensive care of patients with severe 
brain injuries, yet knowledge of post-acute-care recovery 
trajectories remains limited, and predictions of recovery 
are imprecise. Major challenges include lack of large-
scale data sources, early withdrawal of life-sustaining 
treatments (WoLST), inequities in access to care, uncer-
tainties regarding recovery trajectories, inaccurate early 
prognostication, and variable perspectives on the capac-
ity for meaningful recovery.
There is a need to align clinical practices with the cur-
rent evidence and advance recovery science to improve 
prognostication. It is clear from the current science that 
late recovery and functional independence are possible 
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for many patients with severe brain injuries and should 
be considered among the potential outcomes [1–5]. On 
the basis of these findings, some clinical guidelines have 
adopted a default frame of reference that a good outcome 
is possible [6]. Still, 70% of deaths during acute care for 
traumatic brain injury have been associated with WoLST 
[7]. Decisions to WoLST are frequently made during the 
early phase of intensive care unit (ICU) care [8], sug-
gesting limitations in provider knowledge regarding the 
range of possible outcomes [2, 4, 5, 9]. Complicating the 
situation, providers tend to provide overly pessimistic 
prognostic information [10, 11] that may negatively influ-
ence care decisions. Although clinical guidelines [6] have 
incorporated the need to factor in the uncertainty of out-
come in family communications during the first 28 days 
following traumatic and nontraumatic brain injury, this 
approach has not become standard practice [12, 13]. 
Pressure to make decisions early stems from pessimistic 
expectations, beliefs, communication style, health care 
cost considerations, organ donation needs, and hospital 
metrics [12–15]. Many family discussions and decisions 
about goals of care and aggressiveness of management 
may also be influenced by providers’ unconscious biases 
[16]. Practices related to WoLST vary widely throughout 
the world, further complicating analysis.
This article summarizes the results of a gap analysis 
focused on the science of trajectory analysis and predic-
tion in patients with disorders of consciousness (DoC). 
We provide an overview of the current science on DoC 
prognostication and trajectory analysis (current state), 
the science needed to achieve the ideal state (desired 
state), and key scientific needs to achieve the desired 
state.
Procedures
Clinician-scientists (the authors) were identified on the 
basis of their domain expertise in DoC to join a panel that 
met weekly by video teleconference. The principal task 
was to perform a gap analysis regarding the science of 
trajectory analysis and prognostic modeling for patients 
with severe brain injury and DoC. Each author indepen-
dently described the current and desired states, and the 
results were collated by the primary author. Themes were 
identified and organized. The recommendations were 
driven by evidence synthesis, expert opinion, and princi-
ples of feasibility and pragmatism.
Terminology
For the purposes of this article, several terms are defined 
below:
  • Cognitive motor dissociation (CMD): Refers to voli-
tional brain activity detected by task-based functional 
magnetic resonance imaging (MRI) or electroen-
cephalography in patients who, on bedside behavio-
ral assessment, appear to be in a coma, a vegetative 
state (i.e., unresponsive wakefulness syndrome), or 
a minimally conscious state, without the ability to 
communicate with the examiner [17].
  • DoC: Medical conditions that impair conscious-
ness (awareness and/or arousal). DoC include coma, 
vegetative state (i.e., unresponsive wakefulness syn-
drome), minimally conscious state, and CMD [17].
  • Endotype: A subgroup of patients with a condition 
who share similar biological and physiological mech-
anisms, clinical trajectory, outcome, and response to 
therapy.
  • Prognosis: Forecast of the likely outcome from the 
brain injury.
  • Recovery science: The science of trajectory analysis 
and prediction in patients with DoC.
  • Trajectory: The path to an outcome. There may be 
multiple paths to the same outcome.
  • WoLST: Discontinuation of medical treatments nec-
essary to support or extend a patient’s life.
Table 1 Overview of the current state of the science for prognostic modeling and trajectory analysis in patients with dis-
orders of consciousness
Incomplete understanding of the factors that determine prognosis
Limited knowledge about mechanisms of recovery
Limited knowledge regarding how to model prognosis and trajectory
Inconsistent scientific vocabulary (e.g., need for common data elements)
Paucity of integrated data sets across care continuum
Limited research using patient‑centered outcomes
Paucity of knowledge regarding how to communicate prognostic uncertainties
Knowledge of recovery trajectories hampered by decisions to limit life‑sustaining treatments
Care delivery systems impede the ability to translate novel research into practice
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Current state of science
The current state of the science of outcome prognostica-
tion and recovery trajectories is summarized in Table 1. 
Identifying and addressing the current limitations is criti-
cal for advancing recovery science.
Central to the current gaps in recovery science is that 
predicting outcomes and recovery trajectories for indi-
viduals with severe brain injury is often inaccurate and 
has a high degree of uncertainty [18]. There are insuffi-
cient data available to guide decisions adequately, and 
the few data available are not translated effectively to 
the bedside. Inaccuracies and uncertainties of prognos-
tication are multifactorial. There is limited understand-
ing of the biological mechanisms of recovery, the factors 
that determine prognosis, and how to model trajectories. 
The best available predictive tools and models are not 
accurate enough to make early individual patient care 
decisions, yielding, at best, a 70–80% positive predictive 
value [19, 20]. Some of the poor performance of mod-
els is due to an inconsistent assessment of the level of 
responsiveness, a key factor in predicting outcome [21]. 
Approximately 40% of clinical assessments of the level of 
consciousness are inaccurate (i.e., diagnosing individuals 
with demonstrable evidence of consciousness as coma-
tose or vegetative) [22–24]. Reasons for misdiagnosis 
are many, including lack of practical measures for proper 
serial assessments, fluctuating arousal and conscious-
ness, and failure to optimize arousal before assessment 
[25–28].
Existing data sets have several limitations that contrib-
ute to inaccurate prognostication. Many data sets have 
few cases with DoC, do not assess the level of conscious-
ness comprehensively and over time, and do not use 
gold standard assessments of consciousness (e.g., Coma 
Recovery Scale-Revised) [29]. Assessments of mortality 
are confounded by the inclusion of those who die fol-
lowing WoLST (ascertainment bias). The true potential 
outcome trajectories for those who experienced WoLST 
are not known.
Current approaches to outcome research have impor-
tant limitations. Studies are often cross-sectional and 
fail to describe the trajectory of recovery. The outcome 
measurements used in population-based research are 
often broad and lack meaningful application to individual 
patients. There is a lack of widely accepted common data 
elements for this population, and most data sets do not 
include long-term follow-up years after the insult. Large 
data repositories are limited to unlinked data sets that are 
not easily translated to care and decisions at the bedside. 
Obstacles to linking existing data sets include technical, 
administrative, political, regulatory, and data ownership 
challenges. Current clinical practice does not support 
state-of-the-art data collection and data sharing meth-
ods needed to use advanced statistical approaches, such 
as big data multicentric machine learning methods and 
artificial intelligence platforms.
At a systems level, individuals with DoC have limited 
access to quality rehabilitation. All these factors also cre-
ate major inequity of care for patients with DoC, particu-
larly because they are fully dependent on the care culture 
of each ICU and are not able to voice their preference 
themselves.
Desired state of recovery science
Table  2 provides an overview of a vision for the future 
state of DoC recovery science. Achieving this vision will 
require a comprehensive and far-reaching program lev-
eraging science, education, health care delivery systems, 
and policy.
Ideally, clinical data systems should be equipped with 
tools to individualize a patient’s predicted trajectory in 
terms that provide a meaningful picture of the antici-
pated clinical course while accounting for limitations 
in diagnostic/prognostic accuracy that even advanced 
Table 2 Overview of the desired state of the science for prognostic modeling and trajectory analysis in patients with dis-
orders of consciousness
Identification of key preinjury, clinical, intervention, imaging, physiologic, molecular, and genetic factors that determine prognosis
Enhanced understanding of mechanisms and time course of recovery
More accurate modeling of prognosis and trajectory using advanced statistical methods
Comprehensive and widely implemented common data elements
Implementation of data sets for tracking patient data across the entire continuum of care
Patient‑centered outcomes used and integrated into research and clinical practice
Prognostic uncertainties effectively acknowledged and communicated to families
Knowledge base about recovery trajectories in the absence of limitations to care, i.e., withdrawal of life‑sustaining treatments
Integrated health care delivery systems that translate novel research into practice and facilitate access to disorders of consciousness care across the 
recovery continuum
Scientific evidence that supports the development of guidelines for withdrawal of life‑sustaining treatments
S58
assessment tools might have [30]. Ideally, health infor-
mation will flow seamlessly across systems. Assessment 
of prognosis and its communication to family members 
should employ continuously updated population-based 
data that, using advanced tools, tailor predictions for 
individuals using meaningful long-term end points. Fam-
ily discussions should specify both the predictions and 
the levels of confidence in the predictions.
Data elements that most accurately and precisely pre-
dict recovery are incorporated into models that are 
iterative, yielding incremental refinements in model 
prognostic performance as they incorporate new data 
elements and additional patient recovery trajectories. 
Predictors may include demographics, preinjury charac-
teristics, injury/disease-related data, examination find-
ings, diagnostic tools (e.g., imaging, neurophysiology, 
biomarkers), and social variables (e.g., insurance status, 
income, employment, education, primary language, fam-
ily supports, location of residence, caregiver and com-
munity culture and values). Reliable, reproducible, and 
precise tools that can handle the significant heterogene-
ity are needed. This will require extensive data collection 
effort, including family interviews, medical record 
reviews, and imaging results, combined with means of 
reliably interpreting trajectories. Multimodal functional 
assessments that capture meaningful information about 
impairments, activities of daily living, and participa-
tion in life roles are essential to contextualize prognosis 
appropriately for patients and families [5, 31].
Other key factors include functional imaging and elec-
trophysiology studies that assess the brain’s response to 
perturbations as well as genetics and blood-based bio-
markers that facilitate our understanding of personal 
biology, molecular response to injury, and capacity for 
recovery. Technology and approaches will be developed 
to capture meaningful, passive day-to-day data collection 
on the continuum of impairment, needs, and resource 
use, such as the deployment of wearable/portable sen-
sors and telehealth. Applications should be developed to 
translate individualized prognostication algorithms into 
point-of-care tools readily available within electronic 
health records.
Unique and distinct patient groupings (endotypes) 
should be identified by using multisite data repositories 
Fig. 1 At the 2‑year follow‑up, endotype 2 appears markedly different from endotype 3 and appears to have declined from the 1‑year follow‑up. 
However, by the 5‑year follow‑up, endotype 2 progresses past endotype 3. At the present time, variables for identifying markers to assign a patient 
to a particular endotype are lacking. In addition, the common trajectories and meaningful markers (y axis) are not adequately identified
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to facilitate personalized prognostication, decision-mak-
ing, and future care. A priori level of certainty could be 
based on these models. Figure 1 shows theoretical trajec-
tories that individuals with brain injury may experience, 
based on published data using a 1-year postinjury start-
ing point [5]. This represents only a sample of the infinite 
trajectories and time points possible.
As a person with brain injury recovers, the trajectory 
may change, necessitating continuous prognostication 
along the recovery trajectory following an appropriate 
amount of observation and treatment [6]. A patient-cen-
tered model should allow for a reasonable observation 
period for prognostication to occur in a manner to be 
determined on the basis of injury pathology. Figure  1 
acknowledges a wide variation in outcome paths, includ-
ing those that improve rapidly and a subgroup that 
remains unchanged. Defining endotypes will aid in deci-
sion-making and facilitate follow-through on advanced 
directives regarding an acceptable outcome, wherein 
goals-of-care discussions should be aided by research 
using meaningful patient-centered outcome metrics. 
Many prognostic factors have predictive value at a par-
ticular moment in time or cannot be known until a par-
ticular time or recovery milestone.
Advances in prognostication will integrate research 
into health care delivery models designed to fit indi-
vidual patient trajectories. The ideal health care deliv-
ery model addresses the following objectives (Fig. 2): (1) 
accommodates the diverse trajectories possible, (2) maxi-
mizes contributions from all team members, (3) enables 
the provision of progressively updated prognosis, (4) 
facilitates high-quality data collection throughout the 
recovery trajectory, (5) incorporates clinical trials into 
care delivery, and (6) respects the patient’s previously 
expressed values (e.g., religious beliefs) and wishes via 
surrogate decision-makers and advance directives.
Because of the diversity of trajectories, protocols 
addressing the medical and rehabilitation needs of indi-
viduals with DoC require built-in flexibility that allows 
changes to plans as trajectory certainties become estab-
lished. Acute and chronic care should ensure that patient 
progress is monitored and recorded and that lack of 
progress is adequately addressed. Implementation of 
interdisciplinary coma rounds is an important avenue 
to exchange ideas, discuss complicated cases, share per-
spectives, and build research and clinical capacity in 
real time. Available technologies, such as telemedicine, 
may be used to support the interdisciplinary care model 
as needed. Enhanced curricula may support a robust 
training and research agenda on DoC to bridge the gap 
between acute and postacute care for medical and allied 
health fields. Minimum competencies for DoC prognos-
tication and treatment can guide facility-based care for 
individuals with prolonged DoC to reduce the incidence 
and time course of prolonged DoC through both better 
treatment and prognostication [32]. Those receiving care 
in an in-home setting may require ongoing monitoring 
for continued data collection and prognostication.
Research needs to reach state of science: closing the gap
The gap analysis highlighted the need for greater prog-
nostic accuracy and improved communication over the 
continuum of care. Addressing this gap requires system-
atic research to reach the desired state. The expert panel 
identified seven key research goals to pursue. Below we 
summarize the research goals (see Table 3) as well as the 
resources, infrastructure, and research agenda needed to 
support them.
Goal 1: define the variables that predict outcomes
Existing resources:
  • Commonly used scales and predictive tools
  • Ongoing clinical trial network(s) and databases, 
including Transforming Research and Clinical 
Knowledge in Traumatic Brain Injury (TRACK-TBI) 
[33], National Institute on Disability Independent 
Living and Rehabilitation Research (NIDILRR) TBI 
Model Systems [34], National Trauma Data Bank 
[35], Collaborative European NeuroTrauma Effec-
tiveness Research in TBI (CENTER-TBI) [36], and 
EBRAINS [37]
Infrastructure needs:
•  A deep phenotyping Nurses’ Health or Framingham-
like longitudinal study [38, 39] that focuses on patients 
with DoCFig. 2 Key objectives to be addressed in an ideal health care delivery 
model that integrates research and prognostication
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Research agenda
•  Determine the key factors that predict recovery tra-
jectories, including the following: biological mecha-
nisms (personal biology and genetic, proteomic, and 
metabolomic markers reflecting patterns of injury [e.g., 
inflammation] and recovery [e.g., neuronal plasticity 
mechanisms]), demographics, preinjury characteristics 
(premorbidity), injury-related data, diagnostic tools 
(including imaging, neurophysiology, biomarkers, and 
genetics), and social factors (insurance status, income, 
employment, education, primary language, family sup-
ports, location of residence, and caregiver and commu-
nity culture and values)
Goal 2: define meaningful intermediate outcomes at specific 
time points for different endotypes
Existing resources:
Table 3 Research needs for prognostic modeling and trajectory analysis in patients with disorders of consciousness
1. Define the variables that predict outcomes
•Determine the key factors that predict recovery trajectories
2. Define meaningful intermediate outcomes at specific time points for different endotypes
•Identify and define meaningful prognostication milestones along the recovery trajectory
3. Describe recovery trajectories in the absence of limitations to care
•Identify and characterize disorders of consciousness endotypes on the basis underlying biological features, responses to treatments, and individualized 
outcome probability
•Characterize trajectories in the absence of early withdrawal of life‑sustaining treatments
•Define the impacts of interventions, including rehabilitation, on recovery trajectories
4. Harness big data access and develop analytic methods to prognosticate more accurately
•Develop and implement a prospective multisite data repository using common data elements
•Link and harmonize data across existing data sets
•Develop automated cloud‑based bioinformatic approaches to capture meaningful passive day‑to‑day data collection on the continuum of impair‑
ment, recovery, needs, and resource use across participating sites
•Generate clinical decision algorithms based on advanced statistics that have parsed out which elements of clinical care support and optimize disorders 
of consciousness recovery for variable endotypes
•Compare traditional statistical vs. machine learning and neural network approaches to use big data to model and predict patient‑based outcome 
trajectories
•Develop models that use serially collected and progressive assessments to provide a more accurate report of an individual’s prognosis and to project 
the likely recovery trajectory
•Generate clinical decision algorithms that have parsed out which elements of clinical care support and optimize disorders of consciousness recovery 
for variable endotypes
•Create freely available and interactive tools for personalized recovery trajectory predictions using distant data that follow individuals over time
5. Identify key elements and processes for communicating uncertainty regarding culturally specific prognosis over time
•Identify key elements and uncertainties for personalized communication regarding prognosis at various milestones
•Determine best methods and metrics to communicate with families and evidence for how to best relate levels of certainty
•Test impact of training tools on unconscious bias, bioethics, and cultural sensitivity related to withdrawal of life‑sustaining treatment and living with 
disability
6. Identify health care delivery models that facilitate recovery and recovery science
•Identify health care delivery models that facilitate implementation of priorities 1–5
•Develop a continuous care pathway supported by current best practice evidence and embed data collection in that pathway for continuous quality 
improvement
•Establish validity and effectiveness of value‑based care paradigms that increase care quality and access while preventing costly complications and 
declines in function that require increased resource use
7. Advocate for changes in the health care delivery system needed to advance recovery science and implement already‑known best practices
•Partner with disability and advocacy groups to identify effective paths for policy development and implementation for the disorders of consciousness 
community
•Identify the core policy changes needed to support research to enhance prognostic accuracy
•Promote policy changes needed to integrate data collection into clinical care and link clinical and research data sets
•Promote research funding to establish centers of clinical excellence and research networks that facilitate clinical trials in this population
•Disseminate relevant, understandable, and actionable recovery science findings to the general public
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•  Ongoing clinical trial network(s) and databases.
Infrastructure needs:
•  Define meaningful and patient-centered outcomes 
(including the recovery of consciousness; physical 
status; functional abilities; cognitive performance; 
psychological, emotional, and behavioral state; inter-
personal relationships; caregiver burden; academic/
professional reintegration; reintegration into soci-
ety; patient and caregiver quality of life; and financial 
impact of recovery or impairment) for the longitudinal 
study listed under goal 1 and future prognosis and out-
come trajectory research.
Research agenda:
•  Identify and define meaningful prognostication mile-
stones along the recovery trajectory, including address-
ing the following issues:
• What information is necessary for the provision of 
care?
•  What information is optimal or sufficient for 
WoLST?
•  How early and how accurate does prognostication 
need to be? How should this information be used 
and communicated? What are the ethical implica-
tions and responsibilities associated with prognos-
tic assessment and discussion?
•  What are poor and good outcomes from the patient 
and family perspective and how do faith, culture, 
economics, and community shape these experi-
ences?
•  What outcome threshold(s) and outcome trajecto-
ries are meaningful and acceptable/unacceptable?
Goal 3: describe recovery trajectories in the absence 
of limitations to care
Existing resources:
•  In the current treatment environments, WoLST is 
commonly practiced hopelessly, confounding attempts 
to understand recovery potential and trajectories.
Infrastructure needs:
  • A deep phenotyping longitudinal study (as described 
above) that leverages existing brain injury treatment 
environments that do not perform either active or 
passive WoLST is needed to better understand the 
natural recovery course. For example, in many Mid-
dle East and Far East countries (such as Israel [ultra-
Orthodox], Japan, South Korea, Singapore, and main-
land China), there may be access to natural recovery 
data sets with clearly established inclusion/exclusion 
criteria. However, one concern is that even if WoLST 
is not officially practiced, nonsystematic, less aggres-
sive treatment may be provided for those deemed to 
have no chance for recovery.
  • Dedicated research staff and standardized protocols 
are needed to support multisite data collection and 
quality control.
  • Funding to support care for individuals with severe 
brain injury associated with DoC is necessary to eval-
uate recovery trajectories without the confound of 
health care cost and access barriers.
Research agenda:
  • Identify and characterize DoC endotypes on the basis 
of underlying biological features, responses to treat-
ment, and individualized outcome probability that 
incorporates personal biology, premorbidity, and 
other individual characteristics.
  • Characterize trajectories in the absence of early 
WoLST.
• Assess time to recovery and include long-term 
recovery in natural history outcome trajectory 
studies.
•  Create data sets of trajectories of patients in which 
the physician team’s recommendation for WoLST 
was not followed.
•  Characterize timing and reasons for WoLST and 
the impacts of standardized education training on 
goals of care and prognostication on WoLST rates.
  • Define the impacts of interventions on recovery tra-
jectories, including providing or withholding rehabil-
itation (types, intensity, and level of services).
Goal 4: harness big data and develop analytic methods 
to prognosticate more accurately
Existing resources:
  • Ongoing clinical trial network(s) and databases.
  • Current clinical, neuromonitoring, and neuroimag-
ing assessment tools.
Infrastructure needs:
  • A database that incorporates passive, automated data 
collection and clinical assessments across clinical 
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pathways with multisite patient registries with injury, 
epidemiologic, and outcome data using common 
data elements for secondary analysis.
  • Assessments and data collection that can be inte-
grated into the day-to-day clinical practice and 
applied across the full continuum of care, from the 
ICU to rehabilitation, such as Simplified Evaluation 
of Consciousness Disorders [29] and passive move-
ment data (e.g., heart rate variability, electroencepha-
lography, electrophysiology, intracranial pressure, 
cerebral perfusion pressure, and eye-tracking data) 
[29].
•  Generalizable and abbreviated behavioral assess-
ments are needed, such as an abbreviated version of 
the Coma Recovery Scale-Revised [27, 40–42].
  • Multisite repository for biosamples, genetic samples, 
neuroimaging, and neurophysiology studies.
• For diffusion tensor imaging MRI to be used in 
prognostic modeling, standardization of acquisition 
and analysis are needed. Similarly, other imaging-
based tools are being studied for utility in enhanc-
ing prognostication [43–45].
•  Similarly, standardization of acquisition and analy-
sis are fundamental for electroencephalography-
supported diagnoses, such as CMD [46, 47].
•  The genetics of brain injury considers both factors 
that influence the extent of the injury and those 
that impact recovery. An enhanced understanding 
of such factors may allow for a precision therapy 
approach to mitigate injury and enhance recovery 
on a more targeted basis [48]. This can be achieved 
by using genotype as a point of stratification for 
clinical trials [49]. Genetic information collected 
may target variation in inflammation, neurodegen-
eration, neuroplasticity, and neurotransmitters.
•  Temporal response of serum biomarkers, reflecting 
both the central nervous system and the systemic 
response to injury, can serve as a point of stratifi-
cation for clinical decision-making and treatment 
effectiveness as well as a molecular readout about 
response to treatment [50, 51].
•  Blood-based biomarkers are linked to multiple 
aspects of function that are relevant to describing 
recovery trajectories in DoC populations [52].
  • Resources for prospective data management and 
stewardship should provide the capacity for auto-
mated data transfer and quality control. By using a 
system that facilitates managing patients throughout 
the entire continuum of care, standardized processes 
should be developed for data access, use, and dissem-
ination of the results. Integration of health care cost 
data across the entire continuum of care should be 
used to establish cost-effectiveness of different treat-
ment paradigms and resource access.
  • Support for harmonization of retrospective data 
is needed to use existing data and biorepository 
resources. Common data elements that can be used 
for probabilistic vs. deterministic matching of data 
records from databases collecting information about 
different portions of the continuum of care should 
be pursued [53, 54]. Data linkage with public data-
bases, such as the Centers for Medicare and Medic-
aid Services and other publicly accessible databases, 
may enrich cost analyses and capture information on 
social determinants of health [54–58].
  • Outcomes that are meaningful and culturally relevant 
must be defined [59]. Outcome measurement should 
be multidimensional and consider a wide range of 
impairment, functional activities, and participation 
in life roles [49]. Meaningful and culturally relevant 
outcomes should also include family impact and bur-
den [60–63].
Research agenda:
  • Develop and implement a prospective multisite data 
repository using common data elements. This effort 
includes developing approaches to integrate the fol-
lowing types of data into one model to enhance pre-
cision and individualize: interview, premorbidity, 
epidemiologic, clinical, comorbidity, examination, 
imaging, diffusion tensor imaging MRI, functional 
MRI, electrophysiologic, biomarkers, interventions 
received or not received, longitudinal, and outcome. 
This process requires the use of the same battery of 
tests and outcome measures administered in a stand-
ard fashion across data sets and time and requires the 
ability to combine data sets and quality data.
  • Link and harmonize data across existing data sets. 
Doing so will require state-of-the-art data collection 
and data sharing methods needed to use advanced 
statistical approaches. When attempting to link 
siloed data sets, numerous obstacles may be encoun-
tered, including technical, administrative, political, 
regulatory, and data ownership challenges.
  • Develop automated cloud-based bioinformatics 
approaches to capture meaningful passive day-to-
day data collection on the continuum of impairment, 
recovery, needs, and resource use across participat-
ing sites. This will use sensors and data platforms and 
tools that interface in meaningful ways.
  • Compare traditional statistical vs. machine learning 
and neural network approaches to use big data to 
model and predict patient-based outcome trajecto-
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ries. This will bring together multidisciplinary ana-
lytic teams, including those in computational neuro-
science and quantum brain science.
  • Develop models that use serially collected and pro-
gressive assessments to provide a more accurate 
report of an individual’s prognosis and project the 
likely recovery trajectory. This may employ item 
response theory and computerized assessment tech-
nology to select optimal metrics and measures of 
function.
  • Generate clinical decision algorithms based on 
advanced statistics that have parsed out which ele-
ments of clinical care support and optimize DoC 
recovery for variable endotypes.
• Recovery curve measures, such as latent class mod-
eling, may be used to define and support endotype 
definitions.
•  This may employ the use and support of processes 
that involve treatment element extraction to define 
paths that positively impact specific endotypes.
  • Create freely available and interactive tools for per-
sonalized recovery trajectory predictions using dis-
tant data that follow persons over time. This will 
involve the development of research resources in 
commonly translatable tools that can be employed 
worldwide.
Goal 5: identify key elements and processes 
for communicating uncertainty regarding culturally specific 
prognosis over time.
Existing resources:
•  Findings from studies and systematic literature reviews 
may aid the development of protocols for approaching 
and communicating prognosis [6, 64].
Infrastructure needs:
  • Consensus on protocols for how and when to 
approach and communicate prognosis.
  • Training tools to educate physicians and other health 
care providers on effective communication about 
prognosis.
  • Training tools on unconscious bias, bioethics, and 
cultural sensitivity regarding goals-of-care planning 
and WoLST.
  • Training tools on unconscious bias, bioethics, and 
cultural sensitivity regarding multidimensional func-
tion and living with a disability.
Research agenda:
  • Identify key elements and uncertainties for personal-
ized communication regarding prognosis at various 
milestones. Armed with this new knowledge, there 
will be a need to develop the best available evidence-
based guidelines and tools to consistently implement 
improved bedside prognostication. For family discus-
sions, objective data and communication tools will 
help deliver high-quality, evidence-based conversa-
tions informed by cultural variance.
  • Determine best methods and metrics to commu-
nicate with families and evidence to relate levels of 
certainty. Communication standards should include 
the need to update prognosis over time, communi-
cating what is known and not known, and the limi-
tations of certainty at each time point.
  • Test impact of training tools on unconscious bias, 
bioethics, and cultural sensitivity related to WoLST 
and living with a disability. Communication proto-
cols may facilitate eliciting acceptable thresholds of 
care and treatment goals from families/caregivers. 
Communication training tools may include simula-
tion technology to aid clinicians’ implementation.
Goal 6: identify health care delivery models that facilitate 
recovery and recovery science.
Existing resources:
•  Multiple health care delivery models with dyssyn-
chronous data collection and variability in evidence-
based metrics of care
Infrastructure needs:
  • Incorporation of comprehensive data-based assess-
ments with common measures, prognostic assess-
ment tools, patient-specific treatment protocols, 
and pragmatic and translatable research protocols 
into care settings
  • Incorporation of data collection and prognostica-
tion in the home and subacute settings to better 
describe the trajectories and identify the families’ 
needs at various stages of recovery
  • Further implementation of telehealth-based ser-
vices that allow ongoing prognostic data capture 
and assessment over time
  • Enhanced capacity and consistency for DoC care 
and prognostic communication with an emphasis 
on implementation science are necessary
Research agenda:
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  • Identify health care delivery models that facilitate 
the implementation of goals 1–5
  • Develop a continuous care pathway supported by 
current best practice evidence and embed data 
collection in that pathway for continuous quality 
improvement
  • Establish validity and effectiveness of value-based 
care paradigms that increase care quality and access 
while preventing costly complications and declines 
in function that require increased resource use
Goal 7: advocate for changes in the health care delivery 
system needed to advance recovery science and implement 
already‑known best practices.
Existing resources:
•  Global differences in policy and health care institu-
tions
Infrastructure needs:
  • Research to establish stakeholder needs and barri-
ers to health care access and compliance as well as 
to community and caregiver resources that influence 
recovery trajectories
  • A paradigm shift from overly pessimistic clinician 
and public expectations of outcome to acknowledg-
ment of the evidence of the range of outcomes pos-
sible and degree of uncertainty
Policy agenda:
  • Partner with disability and advocacy groups to iden-
tify effective paths for policy development and imple-
mentation for the DoC community:
•  Employ consumers and participatory action 
research concepts to identify key partnerships 
to facilitate the necessary structural and funding 
changes for research progress.
  • Identify the core policy changes needed to support 
research to enhance prognostic accuracy:
•  Define the key elements necessary to facili-
tate research support by evaluating the needs of 
national, international, public, and private interests.
  • Promote policy changes needed to integrate data col-
lection into clinical care and link clinical and research 
data sets:
•  Aggregate leaders in data management and systems 
define the key policy, and regulatory elements need 
to facilitate data capture and meaningfulness for 
DoC research.
  • Promote research funding to establish centers of clin-
ical excellence and research networks that facilitate 
clinical trials in this population:
•  Define the key national and international changes 
needed to establish centers of excellence and linked 
research networks
  • Disseminate relevant, understandable, and actionable 
recovery science findings to the general public for 
active translation of research into practice
Immediate actionable steps:
  • Begin to address and resolve the infrastructure needs.
  • Work with key stakeholders to create awareness of 
the desired state vision and corresponding research 
and policy needs.
Conclusions
A gap analysis driven by evidence synthesis, expert opin-
ion, and principles of feasibility and pragmatism arrived 
at key research needs to advance prognostication in DoC. 
The interdisciplinary Coma Science Work Group on Tra-
jectory Analysis and Prediction, as part of the Neurocriti-
cal Care Society Curing Coma Campaign, has detailed a 
path for advancing the state of science, including infra-
structure, clinical care model development, provider 
education, advocacy, and policy development, to sup-
port our collective research capacity to optimize recov-
ery trajectories for individuals with DoC. Research goals 
needed to achieve this desired state of science are to (1) 
define variables that predict outcomes, (2) define mean-
ingful intermediate outcomes at specific time points for 
different endotypes, (3) describe recovery trajectories in 
the absence of limitations to care, (4) harness big data 
and develop analytic methods to prognosticate more 
accurately, (5) identify key elements and processes for 
communicating uncertainty regarding prognosis over 
time, (6) identify health care delivery models that facili-
tate recovery and recovery science, and (7) advocate for 
changes in the health care delivery system needed to 
advance recovery science and implement already-known 
best practices.
As the needs of recovery science are addressed, the 
study of its implementation will be essential. If successful, 
we believe this road map will advance the state of the sci-
ence and meaningfully impact survivors of DoC and their 
families.
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